JP2007529564A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529564A5
JP2007529564A5 JP2007504334A JP2007504334A JP2007529564A5 JP 2007529564 A5 JP2007529564 A5 JP 2007529564A5 JP 2007504334 A JP2007504334 A JP 2007504334A JP 2007504334 A JP2007504334 A JP 2007504334A JP 2007529564 A5 JP2007529564 A5 JP 2007529564A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
recarbazepine
composition according
swellable substance
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007504334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529564A (ja
Filing date
Publication date
Priority claimed from GB0406379A external-priority patent/GB0406379D0/en
Priority claimed from GB0406738A external-priority patent/GB0406738D0/en
Application filed filed Critical
Priority claimed from PCT/EP2005/002988 external-priority patent/WO2005092294A1/en
Publication of JP2007529564A publication Critical patent/JP2007529564A/ja
Publication of JP2007529564A5 publication Critical patent/JP2007529564A5/ja
Pending legal-status Critical Current

Links

JP2007504334A 2004-03-22 2005-03-21 リカルバゼピンを含む経口マトリックス製剤 Pending JP2007529564A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0406379A GB0406379D0 (en) 2004-03-22 2004-03-22 Organic compounds
GB0406738A GB0406738D0 (en) 2004-03-25 2004-03-25 Organic compounds
PCT/EP2005/002988 WO2005092294A1 (en) 2004-03-22 2005-03-21 Oral matrix formulations comprising licarbazepine

Publications (2)

Publication Number Publication Date
JP2007529564A JP2007529564A (ja) 2007-10-25
JP2007529564A5 true JP2007529564A5 (https=) 2008-05-08

Family

ID=34961345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007504334A Pending JP2007529564A (ja) 2004-03-22 2005-03-21 リカルバゼピンを含む経口マトリックス製剤

Country Status (16)

Country Link
US (1) US20070196488A1 (https=)
EP (1) EP1732519A1 (https=)
JP (1) JP2007529564A (https=)
AR (1) AR048318A1 (https=)
AU (1) AU2005226910B2 (https=)
BR (1) BRPI0509067A (https=)
CA (1) CA2558787A1 (https=)
EC (1) ECSP066860A (https=)
IL (1) IL177826A0 (https=)
MA (1) MA28527B1 (https=)
MX (1) MXPA06010810A (https=)
NO (1) NO20064808L (https=)
PE (1) PE20051156A1 (https=)
RU (1) RU2006137330A (https=)
TW (1) TW200534844A (https=)
WO (1) WO2005092294A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
PE20060124A1 (es) * 2004-03-22 2006-03-07 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
EP1879590A1 (en) * 2005-05-06 2008-01-23 Portela & Ca., S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
US9346760B2 (en) 2011-03-08 2016-05-24 Jubilant Life Sciences Limited Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof
EP2498481A1 (en) 2011-03-09 2012-09-12 Sensirion AG Mobile phone with humidity sensor
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
PT3402488T (pt) 2015-12-18 2022-01-25 Jubilant Generics Ltd Formas de dosagem orais sólidas de eslicarbazepina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
AU2003240654A1 (en) * 2002-05-31 2003-12-19 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
WO2004014391A1 (en) * 2002-08-06 2004-02-19 Novartis Ag Use of carboxamides for the treatment of tinnitus
PE20060124A1 (es) * 2004-03-22 2006-03-07 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina

Similar Documents

Publication Publication Date Title
JP6683886B2 (ja) 薬物動態が改善された放出調節ガンマ−ヒドロキシ酪酸塩製剤
JP2955524B2 (ja) 固体薬剤調製物
EP1397133B1 (en) Rapid onset formulation
JPH09143073A (ja) 持続性ニフエジピン製剤
JP5351490B2 (ja) ニフェジピン含有有核錠剤およびその製法
MX2010009704A (es) Composiciones farmaceuticas de liberacion modifcada que comprenden micofenolato y procesos de estas.
JPH0669965B2 (ja) 固体持続放出医薬製剤
AU2001272243A1 (en) Rapid onset formulation
JPH09500910A (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
BRPI0708059A2 (pt) formulação de niacina de baixo rubor
JP2008543936A5 (https=)
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
JP2007529564A5 (https=)
TW200946142A (en) Tablet
CN110035751A (zh) 一种维利帕尼缓控释药物组合物及其用途
RU2006137330A (ru) Пероральные матричные композиции, содержащие ликарбазепин
JP2010241760A (ja) 不快な味の軽減された口腔内速崩壊錠及びその製造方法
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
KR101697773B1 (ko) 독소필린을 포함하는 변형 방출 조성물
CN101756981B (zh) 一种布洛氯雷伪麻缓释制剂及其制备方法
JP4961338B2 (ja) ナイアシンの経口投与用徐放性組成物
RU2006137329A (ru) Распадающиеся таблетки, содержащие ликарбазепин
FI4032530T3 (fi) Pidennetysti vapautuva furatsidiinikoostumus
TW201201800A (en) A pharmaceutical controlled release composition of losartan
CN101658507A (zh) 一种愈创木酚甘油醚和伪麻黄碱的复方缓释制剂